Pharmaxi LLC is a CRO launched in 2013 by an experienced team with a solid background in clinical trials. Currently, we have 34 employees on board, providing clinical trials for big pharmaceutical companies (Sanofi, AbbVie, Takeda and others).
Pharmaxi conducts clinical trials in Poland, the Czech Republic, Ukraine, and Eastern Europe. If necessary, we can widen our coverage to other countries with trusted partners. Please let us know which countries you are interested in, and we will make preliminary negotiations and prepare the proposal.
Over the years, we have completed projects in the fields of cardiology, endocrinology, gastroenterology, pulmonology, pediatrics, nephrology, gynecology, oncology, neurology, rheumatology, and orphan diseases. It is possible to conduct clinical trials in other therapeutic areas.
There are strong advantages of clinical trials in Poland and Eastern Europe as our local healthcare systems are centralized. A significant benefit of centralization is recruitment in all therapeutic areas. Additionally, the approval process is easier and faster than what may be possible in other countries within the EU. Our doctors and other healthcare professionals are well-trained, so they can offer excellent clinical practice and high-quality data.
Table 1. Pharmaxi Essential Projects
|Investigated Disease||No. Pts||No. Sites|
|Hepatitis C (Poland and Eastern Europe, Latvia, Lithuania, Estonia)||1,450||18|
|Diabetes (Poland and Eastern Europe)||890||40|
|Non alcoholic fatty liver disease (Poland and Eastern Europe)||1100||50|
|Pancreatitis (Poland and Eastern Europe, Khazakhstan)||220||16|
|Juvenile Rheumatoid Arthritis (Poland and Eastern Europe, Belarus)||450||32|
|Acute Pyelonephritis (Poland and Eastern Europe, Belarus, Romania, Bulgaria, Russia, Croatia)||416||28|
While looking forward to hearing from you, we welcome any questions you may have — so please do not hesitate to contact us for further details. We are available to provide any additional information per your request.